Skip to main content
Novartis
language-selector-globe United States | en
Choose Location
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe us
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • About 
      • Novartis in the US 
        • Diversity equity & inclusion  
        • Pay transparency-EPIC 
        • Our code of ethics 
      • Diversity, equity & inclusion  
        • Novartis US EEO / D&I report 2021 
        • Supplier diversity 
      • People and culture 
      • Products 
      • US Country Coordinating Committee 
      • External funding 
      • Contact us 
      Team meeting About
    • Patients and caregivers 
      • Novartis commitment to patients and caregivers 
      • Patient assistance 
      • Diseases 
        • Chronic spontaneous urticaria (CSU) 
        • Hidradenitis suppurativa (HS) 
        • Prostate Cancer (PC) 
        • Paroxysmal Nocturnal Hemoglobinuria (PNH) 
      • Participating in clinical trials 
      • Patient perspectives 
      • Adverse event reporting 
      • The STEP program 
        • Sickle cell disease (SCD) 
        • Program overview 
        • Multiple sclerosis (MS) 
        • Cancer 
        • Application for funding to help address health disparities 
        • Health disparities 
      • Patient resources 
      Patient smiling at doctor image Patients and caregivers
    • Healthcare professionals 
      • Novartis pipeline 
      • Novartis clinical trials 
      • Adverse event reporting 
      • HCP resources 
      • Personalized and Precision Medicine 
      • Health Information Technology Resources 
      Two doctors examining X-ray Healthcare professionals
    • ESG 
      • Ethical behavior 
        • Code of ethics 
        • SpeakUp 
        • PhRMA Code on interactions with healthcare professionals 
        • Business principles 
      • Ethics, risk and compliance 
        • Compliance program 
        • State laws 
        • Corporate integrity agreement 
        • Payments to HCPs & HCOs 
        • Drug Supply Chain Security Act Information 
      • Corporate responsibility 
        • Population health 
        • Novartis in society US reports 
        • Novartis US Foundation 
        • Environmental sustainability 
        • People and communities 
      • Beacon of hope 
        • Beacon of hope: Measurable solutions for health equity 
        • Paving the way for a brighter, more equitable future 
      Novartis East Hanover Campus Landscaping ESG
    • News 
      • News archive 
      • Statements 
      • Stories 
      • Contacts 
      Co-workers having a meeting News
    • Careers 
      • Career search 
      • Meet the teams 
      • Early career 
      • Personal growth 
      • How we work 
      • Employee benefits 
      • Diversity, equity & inclusion 
      • Awards & recognition 
      Meeting in Atrium Careers
    Grandmother, mother and daughter smiling and laughing on a beach Home
  1. Home
  2. Careers
  3. Career Search
  • Sort by Sort ascending
  • Job Title
  • Site
  • Location
  • Division
  • Business Sort descending
  • Functional Area
  • Date Posted
Job Title Site Location Division Business Sort descending Functional Area Date Posted
SSO Finance Specialist Shanghai (Shanghai) China Development Innovative Medicines Research & Development Oct 20, 2024
(高级)医药代表 /(资深)产品专员 Ningbo (Zhejiang Province) China International Innovative Medicines Sales Oct 20, 2024
(高级)地区经理 Shenzhen (Guangdong Province) China International Innovative Medicines Sales Oct 20, 2024
(高级)医药代表 /(资深)产品专员 Urumqi (Xinjiang Province) China International Innovative Medicines Sales Oct 21, 2024
县域主任(主管) Pingdingshan (Henan Province) China International Innovative Medicines Sales Oct 21, 2024
(高级)医药代表 /(资深)产品专员 Xining (Qinghai Province) China International Innovative Medicines Sales Oct 22, 2024
MR Enshi (Hubei Province) China International Innovative Medicines Sales Oct 22, 2024
(高级)医药代表 /(资深)产品专员 Jinhua (Zhejiang Province) China International Innovative Medicines Sales Oct 23, 2024
(高级)医药代表 /(资深)产品专员 Tianjin (Tianjin) China International Innovative Medicines Sales Oct 23, 2024
(高级)医药代表 /(资深)产品专员 Anqing (Anhui Province) China International Innovative Medicines Sales Oct 23, 2024
(高级)医药代表 /(资深)产品专员 Zhenjiang (Jiangsu Province) China International Innovative Medicines Sales Oct 23, 2024
(高级)医药代表 /(资深)产品专员 Shanghai (Shanghai) China International Innovative Medicines Sales Oct 23, 2024
(高级)医药代表 /(资深)产品专员 Qiqihar (Heilongjiang Province) China International Innovative Medicines Sales Oct 24, 2024
(高级)医药代表 /(资深)产品专员 Shijiazhuang (Hebei Province) China International Innovative Medicines Sales Oct 24, 2024
(高级)医药代表 /(资深)产品专员 Qingdao (Shandong Province) China International Innovative Medicines Sales Oct 24, 2024
(高级)医药代表 /(资深)产品专员 Ningbo (Zhejiang Province) China International Innovative Medicines Sales Oct 24, 2024
(高级)医药代表 /(资深)产品专员 Xining (Qinghai Province) China International Innovative Medicines Sales Oct 24, 2024
(高级)医药代表 /(资深)产品专员 Yantai (Shandong Province) China International Innovative Medicines Sales Oct 25, 2024
(高级)医药代表 /(资深)产品专员 Shanghai (Shanghai) China International Innovative Medicines Sales Oct 25, 2024
(高级)医药代表 /(资深)产品专员 Chuxiong (Yunnan Province) China International Innovative Medicines Sales Oct 25, 2024
(高级)医药代表 /(资深)产品专员 Chongqing (Chongqing Province) China International Innovative Medicines Sales Oct 25, 2024
(高级)医药代表 /(资深)产品专员 Chongqing (Chongqing Province) China International Innovative Medicines Sales Oct 25, 2024
(高级)医药代表 /(资深)产品专员 Shanghai (Shanghai) China International Innovative Medicines Sales Oct 27, 2024
Senior Principal Scientist Hyderabad (Office) India Biomedical Research Pharma Research Research & Development Oct 23, 2024
Principal Scientist II Hyderabad (Office) India Biomedical Research Pharma Research Research & Development Oct 23, 2024
Recent Bachelor or Master Graduate Basel (City) Switzerland Biomedical Research Pharma Research Others Oct 22, 2024
TME Profiling Head Office (Japan) (Pharmaceuticals) Japan Biomedical Research Pharma Research Research & Development Jul 07, 2024
Clinical Sciences Trial Leader Head Office (Japan) (Pharmaceuticals) Japan Biomedical Research Pharma Research Research & Development Jul 10, 2024
Computational Medicinal Chemist Cambridge (USA) USA Biomedical Research Pharma Research Data and Digital Oct 22, 2024
In Vivo Senior Scientist - Biology Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Oct 22, 2024
Therapeutic Area Biomarker Lead, Director Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Oct 21, 2024
Senior Scientist, Imaging Data Management Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Oct 21, 2024
Senior Scientist I/II, Immunology– Immunogenicity and Mechanistic Immunology group Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Oct 18, 2024
Senior Scientist - Target Biology and Discovery Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Oct 18, 2024
Research Scientist, Cell Pharmacology - CVM Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Oct 16, 2024
Senior Scientist I/II, Protein Engineering-REQ10019930 Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Oct 16, 2024
Director of Applied AI Research | Data Science (Drug Discovery) Cambridge (USA) USA Biomedical Research Pharma Research Data and Digital Oct 16, 2024
Director, Non-Clinical Statistics Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Sep 02, 2024
Senior Expert Data Science (Immunology) Hyderabad (Office) India Biomedical Research Pharma Research Data and Digital Sep 02, 2024
Senior Expert Data Science- CRM (Cardiovascular, Renal, Metabolism) Hyderabad (Office) India Biomedical Research Pharma Research Data and Digital Sep 02, 2024
Head of R&D Legal, R&D Transactions and Technical Research & Development Cambridge (USA) USA Legal Pharma Research Legal & Intellectual Property & Compl. Oct 15, 2024
Research Scientist, Kidney Pharmacology (BS or MS) Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Oct 09, 2024
Sr Principal Observability Engineer Hyderabad (Office) India Biomedical Research Pharma Research Technology Transformation Oct 17, 2024
Site Head – Biomedical Research India Hyderabad (Office) India Biomedical Research Pharma Research Research & Development Oct 17, 2024
Associate Director, Non-Clinical Statistics Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Oct 11, 2024
Clinical Sciences Trial Leader (Multiple Roles) Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Oct 12, 2024
Asset Strategy Lead - Automation (80-100%*) Basel (City) Switzerland Biomedical Research Pharma Research Research & Development Oct 14, 2024
Clinical Pathologist, Preclinical Safety Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Oct 14, 2024
Senior Scientist - Discovery & Translational Pharmacology (80-100%*) Basel (City) Switzerland Biomedical Research Pharma Research Research & Development Oct 24, 2024
Vendor Management & Governance Manager Basel (City) Switzerland Biomedical Research Pharma Research Research & Development Oct 24, 2024

Pagination

  • ‹ Previous page
  • 1
  • …
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • › Next page

Novartis United States

Navigate Novartis
  • Patients & caregivers
  • Healthcare professionals
  • ESG
  • News
  • Careers
Media center
  • News archive
  • Statements
  • Stories
Our portfolio
  • Novartis clinical pipeline
  • Novartis product portfolio
Other Novartis US websites
  • Oncology HCP resources
  • Medical information
  • Global site
Footer Bottom
© 2024 Novartis Pharmaceuticals Corporation
  • Terms of use
  • Privacy policy
  • Consumer health privacy policy
  • Contacts
  • Site map
  • Web accessibility
Novartis Site Directory
This site is intended for US residents only